IPCA Laboratories Ltd
NSE:IPCALAB
IPCA Laboratories Ltd
NSE:IPCALAB
Price:
1 395
INR
-0.99%
Market Cap:
353.9B
INR
Balance Sheet
Balance Sheet Decomposition
IPCA Laboratories Ltd
IPCA Laboratories Ltd
| Current Assets | 56.8B |
| Cash & Short-Term Investments | 9.4B |
| Receivables | 18.6B |
| Other Current Assets | 28.8B |
| Non-Current Assets | 57.4B |
| Long-Term Investments | 4.3B |
| PP&E | 47.8B |
| Intangibles | 2.3B |
| Other Non-Current Assets | 3.1B |
Balance Sheet
IPCA Laboratories Ltd
IPCA Laboratories Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
630
|
243
|
275
|
276
|
260
|
584
|
1 660
|
2 752
|
12 579
|
2 089
|
|
| Cash |
613
|
227
|
262
|
262
|
254
|
547
|
1 060
|
722
|
917
|
1 388
|
|
| Cash Equivalents |
17
|
16
|
13
|
14
|
6
|
37
|
600
|
2 030
|
11 662
|
701
|
|
| Short-Term Investments |
963
|
1 447
|
1 155
|
1 911
|
3 456
|
3 598
|
6 028
|
10 949
|
9 222
|
6 364
|
|
| Total Receivables |
8 029
|
5 862
|
6 736
|
8 160
|
8 902
|
10 783
|
10 325
|
11 547
|
11 962
|
19 271
|
|
| Accounts Receivables |
6 386
|
4 502
|
5 120
|
6 063
|
6 840
|
8 993
|
8 157
|
9 180
|
10 336
|
17 044
|
|
| Other Receivables |
1 643
|
1 360
|
1 616
|
2 097
|
2 062
|
1 790
|
2 168
|
2 367
|
1 626
|
2 227
|
|
| Inventory |
9 343
|
8 420
|
8 884
|
8 875
|
10 962
|
13 384
|
16 106
|
18 897
|
17 732
|
25 120
|
|
| Other Current Assets |
383
|
249
|
291
|
234
|
199
|
208
|
251
|
428
|
398
|
2 545
|
|
| Total Current Assets |
19 348
|
16 219
|
17 340
|
19 455
|
23 778
|
28 557
|
34 370
|
44 572
|
51 893
|
55 389
|
|
| PP&E Net |
19 532
|
20 355
|
19 755
|
18 954
|
17 826
|
19 933
|
21 465
|
25 026
|
26 946
|
46 632
|
|
| PP&E Gross |
19 532
|
20 355
|
19 755
|
18 954
|
17 826
|
19 933
|
21 465
|
25 026
|
26 946
|
46 632
|
|
| Accumulated Depreciation |
7 135
|
1 536
|
3 145
|
4 788
|
6 441
|
8 185
|
9 938
|
11 891
|
14 306
|
22 535
|
|
| Intangible Assets |
536
|
602
|
552
|
834
|
1 770
|
1 363
|
1 142
|
1 672
|
1 591
|
1 426
|
|
| Goodwill |
472
|
472
|
472
|
472
|
472
|
624
|
466
|
542
|
381
|
906
|
|
| Note Receivable |
954
|
816
|
1 114
|
1 160
|
1 269
|
1 307
|
1 887
|
1 731
|
1 530
|
1 210
|
|
| Long-Term Investments |
193
|
258
|
222
|
175
|
301
|
713
|
1 114
|
2 699
|
3 027
|
3 036
|
|
| Other Long-Term Assets |
213
|
195
|
140
|
123
|
93
|
101
|
240
|
148
|
897
|
2 413
|
|
| Other Assets |
472
|
472
|
472
|
472
|
472
|
624
|
466
|
542
|
381
|
906
|
|
| Total Assets |
41 248
N/A
|
38 917
-6%
|
39 595
+2%
|
41 173
+4%
|
45 507
+11%
|
52 598
+16%
|
60 684
+15%
|
76 389
+26%
|
86 264
+13%
|
111 013
+29%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 060
|
4 211
|
4 577
|
4 235
|
5 243
|
6 099
|
6 649
|
5 577
|
5 251
|
7 761
|
|
| Accrued Liabilities |
429
|
253
|
244
|
199
|
176
|
285
|
300
|
527
|
379
|
949
|
|
| Short-Term Debt |
6 433
|
1 849
|
1 773
|
2 390
|
2 097
|
3 110
|
1 766
|
3 678
|
6 618
|
5 592
|
|
| Current Portion of Long-Term Debt |
1 059
|
1 981
|
1 867
|
1 545
|
1 144
|
738
|
714
|
327
|
1 506
|
2 588
|
|
| Other Current Liabilities |
1 536
|
1 406
|
1 098
|
1 707
|
2 315
|
3 033
|
2 177
|
4 550
|
4 305
|
6 666
|
|
| Total Current Liabilities |
12 517
|
9 700
|
9 559
|
10 076
|
10 975
|
13 264
|
11 605
|
14 659
|
18 058
|
23 556
|
|
| Long-Term Debt |
4 987
|
4 843
|
3 517
|
2 340
|
1 409
|
1 160
|
174
|
4 067
|
6 689
|
6 203
|
|
| Deferred Income Tax |
1 584
|
1 565
|
1 705
|
1 597
|
1 476
|
1 418
|
1 336
|
1 526
|
1 892
|
3 105
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
155
|
136
|
145
|
769
|
733
|
13 948
|
|
| Other Liabilities |
194
|
218
|
261
|
274
|
268
|
345
|
407
|
448
|
473
|
878
|
|
| Total Liabilities |
19 282
N/A
|
16 325
-15%
|
15 043
-8%
|
14 287
-5%
|
14 283
0%
|
16 324
+14%
|
13 667
-16%
|
21 469
+57%
|
27 844
+30%
|
47 691
+71%
|
|
| Equity | |||||||||||
| Common Stock |
252
|
252
|
252
|
252
|
253
|
253
|
254
|
254
|
254
|
254
|
|
| Retained Earnings |
21 137
|
21 936
|
23 859
|
26 119
|
30 431
|
35 382
|
45 657
|
53 540
|
57 219
|
62 189
|
|
| Additional Paid In Capital |
440
|
440
|
440
|
440
|
489
|
489
|
965
|
965
|
965
|
965
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
65
|
|
| Other Equity |
136
|
37
|
1
|
75
|
51
|
151
|
141
|
161
|
18
|
21
|
|
| Total Equity |
21 965
N/A
|
22 592
+3%
|
24 553
+9%
|
26 886
+10%
|
31 224
+16%
|
36 275
+16%
|
47 017
+30%
|
54 920
+17%
|
58 420
+6%
|
63 322
+8%
|
|
| Total Liabilities & Equity |
41 248
N/A
|
38 917
-6%
|
39 595
+2%
|
41 173
+4%
|
45 507
+11%
|
52 598
+16%
|
60 684
+15%
|
76 389
+26%
|
86 264
+13%
|
111 013
+29%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
252
|
252
|
252
|
252
|
253
|
253
|
254
|
254
|
254
|
254
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
